Copyright 2015 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
To the Editor In their systematic review of the Lariat (SentreHeart Inc) left atrial appendage (LAA) ligation system, Chatterjee et al1 question the safety classification of the device, citing adverse events recorded in the US Food and Drug Administration’s (FDA) Manufacturer and User Facility Device Experience (MAUDE) database.1
Srivastava MC, See VY. The Lariat for Left Atrial Appendage Closure: Rehash of Known Literature or a True Analysis?. JAMA Intern Med. 2015;175(11):1868–1869. doi:10.1001/jamainternmed.2015.5399
Customize your JAMA Network experience by selecting one or more topics from the list below.